As of 2024-12-11, the EV/EBITDA ratio of Immunovia AB (publ) (IMMNOV.ST) is -1.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMMNOV.ST's latest enterprise value is 101.10 mil SEK. IMMNOV.ST's TTM EBITDA according to its financial statements is -100.85 mil SEK. Dividing these 2 quantities gives us the above IMMNOV.ST EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 10.9x | 9.2x |
| Forward P/E multiples | 8.7x - 11.3x | 9.4x |
| Fair Price | (4.99) - (6.29) | (5.36) |
| Upside | -756.1% - -926.3% | -804.5% |
| Date | EV/EBITDA |
| 2024-12-10 | -1.00 |
| 2024-12-09 | -1.15 |
| 2024-12-06 | -1.08 |
| 2024-12-05 | -1.07 |
| 2024-12-04 | -1.10 |
| 2024-12-03 | -1.14 |
| 2024-12-02 | -1.20 |
| 2024-11-29 | -1.15 |
| 2024-11-28 | -0.82 |
| 2024-11-27 | -0.76 |
| 2024-11-26 | -0.78 |
| 2024-11-25 | -0.77 |
| 2024-11-22 | -0.72 |
| 2024-11-21 | -0.70 |
| 2024-11-20 | -0.71 |
| 2024-11-19 | -0.69 |
| 2024-11-18 | -0.73 |
| 2024-11-15 | -0.74 |
| 2024-11-14 | -0.76 |
| 2024-11-13 | -0.75 |
| 2024-11-12 | -0.78 |
| 2024-11-11 | -0.84 |
| 2024-11-08 | -0.77 |
| 2024-11-07 | -0.77 |
| 2024-11-06 | -0.72 |
| 2024-11-05 | -0.76 |
| 2024-11-04 | -0.78 |
| 2024-11-01 | -0.75 |
| 2024-10-31 | -0.71 |
| 2024-10-30 | -0.75 |
| 2024-10-29 | -0.77 |
| 2024-10-28 | -0.80 |
| 2024-10-25 | -0.82 |
| 2024-10-24 | -0.83 |
| 2024-10-23 | -0.86 |
| 2024-10-22 | -0.88 |
| 2024-10-21 | -0.80 |
| 2024-10-18 | -0.78 |
| 2024-10-17 | -0.78 |
| 2024-10-16 | -0.79 |
| 2024-10-15 | -0.78 |
| 2024-10-14 | -0.81 |
| 2024-10-11 | -0.83 |
| 2024-10-10 | -0.79 |
| 2024-10-09 | -0.83 |
| 2024-10-08 | -0.84 |
| 2024-10-07 | -1.00 |
| 2024-10-04 | -0.70 |
| 2024-10-03 | -0.72 |
| 2024-10-02 | -0.68 |